Modulim empowers frontline healthcare teams to prevent chronic wounds using specialist-level, point-of-care microvascular imaging and data insights. With more than 50% of diabetic amputations occurring without prior vascular assessment, Modulim brings critical visibility to care settings with it's patented imaging hardware and tech-enabled patient management workflows. The company is raising a Series A to launch its next-generation handheld platform with payer-providers, value-based care organizations, and the U.S. military.